Inhibitors of poly(ADP-ribose) polymerase (PARP) [NEW TOPIC PAGE]

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

---

• The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.  
  Martinez-Useros Javier et al. BioMed research international 2016 20161869304
• Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.  
  George Angela et al. Nature reviews. Clinical oncology 2016 Dec
• PARP Inhibitors in Ovarian Cancer Treatment  
  DR Spriggs et al,NEJM, November 30, 2016
• Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples.  
  Badoer Cindy et al. Oncotarget 2016 Oct
• Novel BRCA1 and BRCA2 Tumour Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.  
  Weren Robbert D A et al. Human mutation 2016 Oct

more